Status:
UNKNOWN
Clinical Trial of 3D Telemedicine
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborating Sponsors:
University of Strathclyde
Microsoft Corporation
Conditions:
Telemedicine
Surgery
Eligibility:
All Genders
16-95 years
Phase:
NA
Brief Summary
This randomised controlled trial will provide definitive answers to whether a 3D telemedicine system makes a remote consultation more similar to meeting a doctor face-to-face, than a 2D Telemedicine c...
Detailed Description
1. Pre-study Protocol Optimisation Focus group research and co-design with patients from 2019 to 2021, has been used to allow protocol optimisation prior to the RCT. This part of the research project ...
Eligibility Criteria
Inclusion
- Patients who have undergone a plastic surgery procedure including:
- free flap reconstruction
- pedicled flap reconstruction
- skin graft reconstruction
- major cancer surgery
- major trauma and burns surgery
- Patients able to read and understand English
- Patients able to give informed consent
Exclusion
- Patients not meeting the inclusion criteria
- Patients who do not have capacity to consent
- Patients who are registered blind or deaf
- Patients undergoing minor operations only including:
- primary closure
- minor local flap reconstruction (for example minor surgery for benign lesions or low risk tumours including Basal or Squamous Cell Carcinoma)
- minor hand surgery not requiring major flap reconstruction (for example nail bed repair, digital nerve repair, infections).
- Patients with perineal reconstruction given the sensitive area of examination
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05227235
Start Date
August 1 2022
End Date
March 31 2023
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Canniesburn Regional Plastic Surgery and Burns Unit
Glasgow, Scotland, United Kingdom, G4 0SF